Fang Fei, Chen Dewei, Yu Liming, Dai Xin, Yang Yuyu, Tian Wenfang, Cheng Xian, Xu Huihui, Weng Xinyu, Fang Mingming, Zhou Jiliang, Gao Yuqi, Chen Qi, Xu Yong
From the State Key Laboratory of Reproductive Medicine, and Atherosclerosis Research Center, Provincial Key Laboratory of Cardiovascular Disease; and Department of Pathophysiology, Nanjing Medical University, Nanjing, China.
Circ Res. 2013 Sep 27;113(8):986-96. doi: 10.1161/CIRCRESAHA.113.301296. Epub 2013 Aug 20.
Endothelial dysfunction inflicted by inflammation is found in a host of cardiovascular pathologies. One hallmark event in this process is the aggregation and adhesion of leukocyte to the vessel wall mediated by the upregulation of adhesion molecules (CAM) in endothelial cells at the transcriptional level. The epigenetic modulator(s) of CAM transactivation and its underlying pathophysiological relevance remain poorly defined.
Our goal was to determine the involvement of Brahma related gene 1 (Brg1) and Brahma (Brm) in CAM transactivation and its relevance in the pathogenesis of atherosclerosis.
In the present study, we report that proinflammatory stimuli augmented the expression of Brg1 and Brm in vitro in cultured endothelial cells and in vivo in arteries isolated from rodents. Overexpression of Brg1 and Brm promoted while knockdown of Brg1 and Brm abrogated transactivation of adhesion molecules and leukocyte adhesion induced by inflammatory signals. Brg1 and Brm interacted with and were recruited to the CAM promoters by nuclear factor κB/p65. Conversely, depletion of Brg1 and Brm disrupted the kinetics of p65 binding on CAM promoters and crippled CAM activation. Silencing of Brg1 and Brm also altered key epigenetic changes associated with CAM transactivation. Of intrigue, 17β-estradiol antagonized both the expression and activity of Brg1/Brm. Most importantly, endothelial-targeted elimination of Brg1/Brm conferred atheroprotective effects to Apoe(-/-) mice on a Western diet.
Our data suggest that Brg1 and Brm integrate various proinflammatory cues into CAM transactivation and endothelial malfunction and, as such, may serve as potential therapeutic targets in treating inflammation-related cardiovascular diseases.
炎症导致的内皮功能障碍在许多心血管疾病中都有发现。这一过程中的一个标志性事件是白细胞通过内皮细胞中粘附分子(CAM)在转录水平上的上调介导而聚集并粘附于血管壁。CAM转录激活的表观遗传调节因子及其潜在的病理生理相关性仍不清楚。
我们的目标是确定与Brahma相关的基因1(Brg1)和Brahma(Brm)在CAM转录激活中的作用及其在动脉粥样硬化发病机制中的相关性。
在本研究中,我们报告促炎刺激在体外培养的内皮细胞中以及在从啮齿动物分离的动脉中体内均可增强Brg1和Brm的表达。Brg1和Brm的过表达促进了炎症信号诱导的粘附分子转录激活和白细胞粘附,而Brg1和Brm的敲低则消除了这种作用。Brg1和Brm与核因子κB/p65相互作用并被招募到CAM启动子上。相反,Brg1和Brm的缺失破坏了p65在CAM启动子上结合的动力学并削弱了CAM的激活。Brg1和Brm的沉默也改变了与CAM转录激活相关的关键表观遗传变化。有趣的是,17β-雌二醇拮抗Brg1/Brm的表达和活性。最重要的是,在内皮细胞中靶向消除Brg1/Brm对高脂饮食喂养的Apoe(-/-)小鼠具有抗动脉粥样硬化作用。
我们的数据表明,Brg1和Brm将各种促炎信号整合到CAM转录激活和内皮功能障碍中,因此可能作为治疗炎症相关心血管疾病的潜在治疗靶点。